We’re moving!

March 20, 2019

Prodrome Sciences opens up new laboratory facility in California

We are pleased to announce the opening of our new 4,000 square foot laboratory facility in Temecula, California. The new facility will house our advanced, high-resolution mass spectrometry research and development laboratory, CLIA biomedical laboratory, and cGMP therapeutics manufacturing laboratory.

Prodrome Sciences’ first therapeutic product, a plasmalogen bioprecursor, is ready for manufacturing. The plasmalogen bioprecursors are natural plasmalogen supplements designed to maintain optimal blood and brain plasmalogen levels. High blood and brain levels of plasmalogens are associated with a lower risk for neurodegenerative diseases such as Alzheimer’s and Parkinson’s.

We would like to thank all of our North American and international collaborators for their continued support of our research during our rebuilding phase this past two and a half years.

Our new address is:
40880 County Center Drive, Suite R
Temecula, California

Contact us for more detailed information.

About Prodrome Sciences Inc.

Prodrome Sciences researches prodromes of diseases – how to detect them, what causes them, and how to return high-risk prodrome states back to a healthy state before the disease develops. We use our advanced diagnostic technology for blood tests to detect disease prodromes and in our natural therapeutic programs to restore an unhealthy, high-risk prodrome state to a healthy, low-risk state. Our goal is to reduce the number of people that develop and die from disease and to promote optimal health.

Keep in touch

©2019 Prodrome Sciences Inc.